GeminIQ

AVAI

AVAI BIO, INC.
$0.12previous close on: 9/11/2026

Company Information

Company Name
AVAI BIO, INC.
CIK
CIK0001740797
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
AVAI: OTC
Fiscal Year End
March 31
Owner Organization
06 Technology
SIC
7374
SIC Description
Services-Computer Processing & Data Preparation
Ticker
AVAI

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
—
Shares purchased (TTM)
0
Shares sold (TTM)
0
Buy ratio (TTM)—

Institutional Sentiment

As of
—
Institutional shares owned
—
Shares outstanding
—
Ownership
—

Earnings Market Reaction

Filing date
2026-08-13
Price on filing date
—
1-month reaction
-2.40%
3-month reaction
Pending
Drift continued5/8 (63%)
Faded / reversed3/8 (38%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value000000000000
Financing Receivable Loan In Process-0----------
Accounts Notes And Loans Receivable Net Current0-----------
Prepaid Expense Current00000000000-
Prepaid Rent---------000
Assets Current000000000000
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization-------0-0-0---
Furniture And Fixtures Gross------000---
Assets Noncurrent
Intangible Assets Net Excluding Goodwill---00000000-
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment----------0--0
Property Plant And Equipment Net---------000
Other Assets
Other Assets10---0------
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets------------0
Production Costs Cumulative----------0-
Intangible Assets Gross Excluding Goodwill000--0------
Assets110000000000
Other Assets Noncurrent00----------
Accrued Payroll Taxes Current-----------0
Accounts Payable And Accrued Liabilities Current----------1-
Liabilities And Stockholders Equity
Finite Lived Intangible Assets Gross-----------0
Intangible Assets Current-----------0
Development Costs Cumulative----------00
Accounts Payable Current221111212100
Loans And Leases Receivable Loans In Process----------00
Convertible Notes Payable Current110100000000
Long Term Debt Current-----------0
Long Term Loans Payable----------0-
Notes Payable--------00--
Other Liabilities Current1111111110--
Notes And Loans Payable11100-------
Liabilities Current433322222221
Liabilities433322222221
Preferred Stock Value00000000000-
Sale Of Stock Price Per Share----------25,000.0025,000.00
Preferred Stock Value Outstanding0000000000--
Common Stock Value000000000000
Additional Paid In Capital333322221111
Retained Earnings Accumulated Deficit-6-6-6-5-5-4-5-4-4-3-3-2
Stockholders Equity Note Subscriptions Receivable------------1
Stockholders Equity-3-3-3-2-2-2-2-2-2-1-1-1
Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable-----------0
Liabilities And Stockholders Equity110000000000
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.00-
Preferred Stock Shares Authorized2020202020202020202020-
Preferred Stock Shares Issued1111111111111111101010-
Preferred Stock Shares Outstanding11111111111111111010105
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.00-
Common Stock Shares Authorized500500500500500500500500500500500-
Common Stock Shares Issued15415313813813813713713211711785-
Shares Outstanding1541531381381381371371321171178565

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

AVAI BIO, INC. (AVAI) — SEC Financial Statements & Analysis

AVAI BIO, INC. (AVAI) is a services-computer processing & data preparation company, incorporated in NV. AVAI BIO, INC. trades on OTC as: AVAI. AVAI BIO, INC. (AVAI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, AVAI BIO, INC. carries a market cap of $19.70M, a P/E ratio of -7.06x, a P/B ratio of -6.11x, an enterprise value of $21.10M, and an EV/EBITDA multiple of -7.63x. On profitability, it posts a Return on Equity (ROE) of 106.99% and a Return on Assets (ROA) of -595.30%. Per share, it reports EPS of $-0.02, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 2119.19% year-over-year and EPS growth of 1881.95% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.04x, working capital of $-3.86M, a debt-to-equity ratio of -1.25x, a debt ratio of 5.07, an interest coverage ratio of -7.35x, free cash flow of $-1.18M (TTM), and net debt of $1.40M. Figures sourced from SEC EDGAR.

Market Cap
$19.70M
P/E TTM
-7.06x
EPS TTM
$-0.02
P/B TTM
-6.11x
ROE TTM
106.99%
ROA TTM
-595.30%
Debt To Equity
-1.25x
Free Cash Flow TTM
$-1.18M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is AVAI BIO, INC. in?

AVAI BIO, INC. (AVAI) operates in the Services-Computer Processing & Data Preparation industry.

What exchange does AVAI trade on?

AVAI BIO, INC. (AVAI) trades on the OTC.

Where is AVAI BIO, INC. incorporated?

AVAI BIO, INC. is incorporated in NV.

When was AVAI BIO, INC. (AVAI)'s most recent SEC filing?

AVAI BIO, INC. (AVAI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.

What is AVAI's market cap?

AVAI BIO, INC. (AVAI) has a market capitalization of $19.70M as of 2026-06-30.

What is AVAI's EPS (earnings per share)?

AVAI BIO, INC. (AVAI)'s trailing twelve month EPS is $-0.02 as of 2026-06-30.

What is AVAI's ROE (return on equity)?

AVAI BIO, INC. (AVAI)'s trailing twelve month Return on Equity (ROE) is 106.99% as of 2026-06-30.

What is AVAI's ROA (return on assets)?

AVAI BIO, INC. (AVAI)'s trailing twelve month Return on Assets (ROA) is -595.30% as of 2026-06-30.

What is AVAI's EV/EBITDA?

AVAI BIO, INC. (AVAI)'s trailing twelve month EV/EBITDA is -7.63x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial